Diabetic Complications: An Update on Pathobiology and Therapeutic Strategies

Area of Science:

• Endocrinology and Metabolism
• Vascular Biology
• Diabetology

Background:

• Diabetes mellitus, both type I and type II, leads to severe secondary complications.
• These complications significantly increase morbidity and mortality, affecting both microvascular and macrovascular systems.
• Current treatments manage, but do not prevent or cure, these debilitating conditions.

Purpose of the Study:

• To review the cellular mechanisms underlying the development and progression of diabetic complications.
• To discuss current therapeutic strategies for managing diabetic complications.
• To identify potential avenues for future drug discovery in this field.

Main Methods:

• Literature review of cellular and molecular alterations in diabetes.
• Analysis of established pathophysiological pathways contributing to diabetic complications.
• Synthesis of information on current clinical therapeutic paradigms.

Main Results:

• Long-standing diabetes induces cellular and molecular changes damaging blood vessels.
• Microvascular complications include neuropathy, nephropathy, and retinopathy.
• Macrovascular complications encompass heart disease and stroke.

Conclusions:

• A deeper understanding of diabetic complication pathophysiology is crucial for therapeutic advancement.
• Current therapies offer partial relief but fail to prevent or resolve complications.
• Future success in drug discovery hinges on identifying key factors driving disease progression.